Infectious Diseases
Laboratory Services
Laboratory Services
Medpace Advantages for Infectious Disease Studies
Infectious disease studies have grown in complexity with traditional microbiology methods increasingly supplemented with new molecular techniques, providing rapid and accurate data, facilitating improved understanding of disease mechanism and enhanced clinical outcomes. Medpace’s central laboratories’ in house capabilities coupled with strategic laboratory partnerships with top labs in microbiology and virology provide the specific testing required for each study. This approach streamlines timelines, simplifies requirements for sites, and provides a centralized model for communication.
Key benefits include:
- Access to top research scientists who are therapeutically focused on infectious disease, deliver regulatory-quality reports and meet the tight timelines demanded in ID trials
- With Medpace central labs coordinating the shipping between sites and labs around the world, logistics are greatly simplified, resulting in higher efficiency
- Specialty labs integrate seamlessly with Medpace’s full-service approach to clinical trial management
WHitepaper:
Investigating the Human Microbiome Using Next-Generation Sequencing
Central Lab Services
Our fully-integrated microbiology and central laboratory model streamlines your program and results in more consistent and higher quality outcomes.
- Bacterial Identifications
- Fungal Identifications
- Genotyping
- In Vitro Drug Susceptibility Testing
- Infectious Disease Serology
- Microbial Cultures
- Molecular Characterization
- Phage Testing
- TB Testing (Quantiferon Gold)
- Viral Loads
Microbiology Capabilities
Medpace’s central laboratories offer comprehensive microbiology capabilities that support the specific testing required for each study. Our state-of-the-art microbiology suites, located at Medpace’s Cincinnati, OH, and Shanghai, China central lab are equipped with advanced technology and staffed by experienced medical microbiologists, ensuring high-quality and reliable results while adhering to the strictest national and international standards.
By combining traditional microbiological methods with cutting-edge molecular techniques, we deliver comprehensive insights that drive the success of your clinical trials. Our team works closely with Sponsors to design customized testing protocols that meet study requirements, enhancing the efficiency and efficacy of the drug development process. Our labs also maintain strict adherence to regulatory standards and follows Good Clinical Practice (GCP) and Clinical Laboratory Improvement Amendments (CLIA) regulations. For standards, we follow Good Clinical Laboratory Practice (GCLP) and College of American Pathologists (CAP).
FACT SHEET:
COMPREHENSIVE MICROBIOLOGY SERVICES
Medpace Central Labs:
COVID-19 Laboratory Testing
COVID-19 Testing Capabilities
Medpace is committed to assist in the fight against COVID-19, which aligns with our mission of accelerating the global development of safe and effective medical therapeutics. We have a highly experienced infectious disease team, including medical, regulatory, operational, and laboratory experts who have extensive experience designing and conducting infectious disease clinical trials. Our team is actively working with the global regulatory authorities and Sponsors responding to COVID-19.
To serve our Sponsors in their COVID-19 programs, Medpace has expedited COVID-19 assay validations to meet clinical trial testing standards.